Shareholder Suit Seeks To Halt MAM-Emera Merger
The complaint, lodged Friday in the U.S. District Court for the District of Maine, alleged that the sale process was defective and that the Emera subsidiary bought MAM for the unfair price of $75 million, or $45 a share.
“Given the company’s future prospects, the consideration shareholders are to receive is inadequate,” the complaint said. It named MAM,...
To view the full article, register now.